E
Sell
3/24/2025Downgrade
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) was downgraded to E from E+ on 3/24/2025 due to a decline in the volatility index and total return index.
E
Sell
3/7/2025Upgraded
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) was upgraded to E+ from E on 3/7/2025 due to a substantial increase in the solvency index, growth index and volatility index. The quick ratio increased from 0.09 to 1.25, earnings per share increased from -$1.5872 to -$0.4002, and EBIT increased 41.76% from -$3.05M to -$1.78M.
E
Sell
12/27/2024Downgrade
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) was downgraded to E from E+ on 12/27/2024 due to a decline in the volatility index and total return index.
E
Sell
12/12/2024Upgraded
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) was upgraded to E+ from E on 12/12/2024 due to an increase in the volatility index.
E
Sell
11/27/2024Downgrade
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) was downgraded to E from E+ on 11/27/2024 due to a significant decline in the solvency index, volatility index and growth index. EBIT declined 105.83% from -$1.48M to -$3.05M, the quick ratio declined from 1.69 to 0.09, and earnings per share declined from -$0.965 to -$1.5872.
E
Sell
5/1/2023Upgraded
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) was upgraded to E+ from E on 5/1/2023 due to an increase in the volatility index, valuation index and solvency index.
E
Sell
2/1/2023Upgraded
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) was upgraded to E from E- on 2/1/2023 due to an increase in the efficiency index and total return index.
E
Sell
11/23/2022None
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) was downgraded to E- from U on 11/23/2022.
